We present an update on the molecular pathology of prostate cancer, including its molecular classification, key driver gene and other somatic alterations, as well as current concepts around biomarker testing, with an emphasis on information pertinent to the surgical pathologist for their daily practice and communications with clinicians. For in depth coverage of the molecular and clinical features of potential prostate cancer precursors, including high grade prostatic intraepithelial neoplasia, the readers are directed to recent publications.
Pereira et al. (2026) studied this question.